Periodontal and soft tissue prevention strategies for the adolescent dental patient.
Recent research has refocused attention on the contribution of periodontal health to the general health of patients at various ages. This article describes changes in the periodontal tissues of adolescent dental patients related to hormonal fluctuations, lack of proper oral hygiene, and risk-taking behaviors. Attention is placed on the development and prevention of acute and chronic gingival conditions in addition to gingival tissue enlargement as one side effect of certain medications.
Studen-Pavlovich
Deborah
D
School of Dental Medicine, University of Pittsburgh, 3501 Terrace Street, 366 A Salk Hall, Pittsburgh, PA 15261, USA. das12@pitt.edu
Ranalli
Dennis N
DN
D000293:Adolescent; D000662:Amphetamines / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002908:Chronic Disease; D003524:Cyclosporins / Q000009:adverse effects; D019214:Gingival Overgrowth / Q000139:chemically induced / Q000517:prevention & control; D005889:Gingival Recession / Q000209:etiology; D005891:Gingivitis / Q000209:etiology / Q000628:therapy; D005892:Gingivitis, Necrotizing Ulcerative / Q000209:etiology / Q000628:therapy; D006561:Herpes Simplex / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D010497:Pericoronitis / Q000517:prevention & control; D010510:Periodontal Diseases / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D010672:Phenytoin / Q000009:adverse effects
D000662:Amphetamines; D000927:Anticonvulsants; D000697:Central Nervous System Stimulants; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D010672:Phenytoin